Conversely, we administered FBXL6 siRNA to NAFLD mice prior to EX‐IR training and found that NAFLD‐associated hepatic inflammation, including lipid deposition and the AA/TB4/PGH2 concentration, was significantly reduced (Figure S5E,F, Supporting Information). This evidence concerns the gene FBXL6 and metabolic dysfunction-associated steatotic liver disease.